comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 19:25:43 - browse：95

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： What it’s like to watch children die of measles

focus

WSS

What it’s like to watch children die of measles

EQRx, failed developer of low

No plane should take off without an EpiPen onboard

UnitedHealth quietly bought dozens of outpatient centers

‘Oppenheimer’ and the risks of AI in health care

No plane should take off without an EpiPen onboard

entertainment

comprehensive

explore

In age of alternative facts, a scholarly course on calling out crap

5 important ways Henrietta Lacks changed medical science

Wildfire smoke exposes gaps in outdoor worker protections

Micronoma's microbiome cancer diagnostic approach under fire

United colonoscopy coverage change 'may cost lives,' doctors say

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Supreme Court strikes down use of affirmative action

Physician groups backed by private equity giant lobby on mergers

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UnitedHealth quietly bought dozens of outpatient centers

leisure time

Sen. Paul opposes bill to ban Chinese biotechs

What to expect as Trump is arraigned on his Jan 6. indictment

National panel will explore requiring free Covid tests

No plane should take off without an EpiPen onboard

Amylyx ALS drug fails large clinical trial

The high personal cost of affirmative action for Black doctors

hotspot

explore

focus

hotspot